SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

~13 mi. (Leesburg, Virginia, +163 more cities)

Investigational Site Number :8400025

CEACAM5 Expression

Non-Squamous Non-Small Cell Lung Carcinoma

tusamitamab ravtansine

chemotherapy, +1 more type

An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread

~13 mi. (Leesburg, Virginia, +44 more cities)

Virginia Cancer Specialists (Leesburg) - USOR

ER Negative, +2 more biomarkers

Breast Carcinoma, +2 more conditions

BMS-986249, +2 more drugs

immunotherapy

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

~18 mi. (Gaithersburg, Maryland, +822 more cities)

Kaiser Permanente-Gaithersburg Medical Center

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

carboplatin, +3 more drugs

chemotherapy

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

~18 mi. (Gaithersburg, Maryland, +954 more cities)

Kaiser Permanente-Gaithersburg Medical Center

Non-Small Cell Lung Carcinoma

crizotinib, +4 more drugs

chemotherapy, +2 more types

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

~18 mi. (Gaithersburg, Maryland, +577 more cities)

Kaiser Permanente-Gaithersburg Medical Center

Non-Small Cell Lung Carcinoma

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

~18 mi. (Gaithersburg, Maryland, +923 more cities)

Kaiser Permanente-Gaithersburg Medical Center

ALK Fusion

Non-Small Cell Lung Carcinoma

crizotinib

targeted therapy

Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

~19 mi. (Rockville, Maryland, +206 more cities)

Maryland Oncology Hematology - Rockville Aquilino Cancer Center

Non-Squamous Non-Small Cell Lung Carcinoma

nivolumab, +1 more drug

immunotherapy, +1 more type

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

~19 mi. (Rockville, Maryland, +191 more cities)

Cancer Trials Support Unit

del(19)(q10), +3 more biomarkers

Low Grade Glioma, +3 more conditions

3-dimensional conformal radiation therapy, +5 more drugs

chemotherapy, +1 more type

A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

~19 mi. (Rockville, Maryland, +137 more cities)

Maryland Oncology Hematology, PA

FGFR1 Amplification, +11 more biomarkers

Urothelial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

~19 mi. (Rockville, Maryland)

AIDS Malignancy Consortium

Anal Squamous Cell Carcinoma

capecitabine, +4 more drugs

chemotherapy, +2 more types

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

~19 mi. (Rockville, Maryland, +65 more cities)

GSK Investigational Site

HAVCR2 Expression

Malignant Solid Tumor, +1 more condition

carboplatin, +7 more drugs

chemotherapy, +1 more type

TUSC2-nanoparticles (GPX-001) and Osimertinib in Patients With Stage IV Lung Cancer Who Progressed on Osimertinib Alone

~19 mi. (Rockville, Maryland, +4 more cities)

Maryland Oncology Hematology

EGFR Mutation

Non-Small Cell Lung Carcinoma

osimertinib, +1 more drug

targeted therapy